Pfizer Says Its Experimental Pill Reduces Risk Of Hospitalization, Death From COVID-19
Drugmaker Pfizer said Friday its experimental pill designed to fight coronavirus reduced the risk of hospitalization and death for high-risk patients taking part in a trial of the drug.